Loading clinical trials...
Loading clinical trials...
The main objective of the current study is to investigate whether consumption of soluble fibers (isomaltodextrin \[IMD\], partially digestible maltodextrin) and RS4 starch will lower postprandial glycemia as well as postprandial insulin in human subjects with relatively high fasting blood glucose, when consumed with a specific amount of digestible carbohydrate (rice porridge). The primary outcome of the study is the effect of fibers on postprandial blood glucose, whereas the secondary outcome will be its effect on postprandial blood insulin.
Age
22 - 60 years
Sex
ALL
Healthy Volunteers
Yes
Purdue University
West Lafayette, Indiana, United States
Start Date
December 7, 2021
Primary Completion Date
March 9, 2022
Completion Date
March 9, 2022
Last Updated
April 27, 2022
24
ACTUAL participants
Control
OTHER
Isomaltodextrin Low Dose
OTHER
Isomaltodextrin High Dose
OTHER
GPC partially digestible maltodextrin
OTHER
Resistant Starch Type 4
OTHER
Lead Sponsor
Purdue University
Collaborators
NCT04564391
NCT03851627
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions